SIRT7 and prostate carcinoma: The exploration of SIRT7’s involvement in metastatic processes reveals its critical role in the epigenetic reprogramming associated with EMT in prostate carcinomas, with the depletion of SIRT7 in both epithelial and mesenchymal cancer cells reversing aggressive traits and underscoring its function as a regulator of metastatic behavior [171].